FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

The FDA approved a supplemental application for TUDORZA PRESSAIR (aclidinium bromide) submitted by Covis Pharma US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TUDORZA PRESSAIR (ACLIDINIUM BROMIDE)

Snippet

SUPPL AP for TUDORZA PRESSAIR (ACLIDINIUM BROMIDE)